Literature DB >> 15734765

Diuretic usage in heart failure: a continuing conundrum in 2005.

S Gupta1, L Neyses.   

Abstract

Several large well-designed clinical trials have shown that the use of diuretics is beneficial in patients with hypertension. However, similarly robust data regarding their role in chronic heart failure are lacking. Historically, diuretics were developed for treatment of sodium and water retention in oedematous disorders and clinically, they remain the most potent drugs available to relieve symptoms and eliminate oedema in the congested patient with heart failure. In the non-congested patient, however, diuretics continue to be used on a purely clinical basis without sufficient characterization of benefits, adverse effects, and potential influence on mortality. There are also concerns that chronic diuretic usage can cause adverse vascular effects, unfavourable neuroendocrine activation, electrolyte imbalances, and life-threatening arrhythmias. In this article, we review the limited evidence available regarding the benefits and perils of using diuretics in heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734765     DOI: 10.1093/eurheartj/ehi176

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

Review 1.  Ultrafiltration in decompensated heart failure.

Authors:  Brian E Jaski; David Miller
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Is amiodarone safe in heart failure?

Authors:  Michele Coceani; Rita Mariotti
Journal:  BMJ       Date:  2006-02-11

4.  Diuretic effect of extracts, fractions and two compounds 2α,3β,19α-trihydroxy-urs-12-en-28-oic acid and 5-hydroxy-3,6,7,8,4'-pentamethoxyflavone from Rubus rosaefolius Sm. (Rosaceae) leaves in rats.

Authors:  Priscila de Souza; Thaise Boeing; Lincon Bordignon Somensi; Camile Cecconi Cechinel-Zanchett; Jairo Kenupp Bastos; Marcel Petreanu; Rivaldo Niero; Valdir Cechinel-Filho; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-24       Impact factor: 3.000

Review 5.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

6.  Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.

Authors:  Alberto Palazzuoli; Marco Pellegrini; Beatrice Franci; Matteo Beltrami; Gaetano Ruocco; Stefano Gonnelli; Gianni D Angelini; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2014-08-03       Impact factor: 3.397

7.  Arginine vasopressin antagonist tolvaptan in the treatment of heart failure: a meta-analysis of randomized controlled trials.

Authors:  Chao-Jun Yang; Jun Yang; Jian Yang; Zhi-Xing Fan
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 8.  Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ionut Nistor; Iris Bararu; Maria-Cristina Apavaloaie; Luminita Voroneanu; Mihaela-Dora Donciu; Mehmet Kanbay; Evi V Nagler; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2014-10-04       Impact factor: 2.370

9.  Diuretic effects of young fruit extracts of bombax ceiba L. In rats.

Authors:  S S Jalalpure; N B Gadge
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

10.  Serum uric acid as an index of impaired renal function in congestive heart failure.

Authors:  Yu Tian; Ying Chen; Bao Deng; Gang Liu; Zhen-Guo Ji; Qing-Zhen Zhao; Yu-Zhi Zhen; Yan-Qiu Gao; Li Tian; Le Wang; Li-Shuang Ji; Guo-Ping Ma; Kun-Shen Liu; Chao Liu
Journal:  J Geriatr Cardiol       Date:  2012-06       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.